- Required
Quantity
- Place of Origin
- South Korea
- Brand name
- Optical Q
- Payment Terms
- T/T
- Production
method - OBM
- Shipping /
Lead Time - Negotiable / Negotiable
- Keyword
- diagnostic devices, ivd, poct, fluorescence immunoassay,
- Category
- Chemical Reagents & Products
1 OptiBio Co., Ltd.
Supplier Activity
tradeKorea provides seller activity to buyers throu gh seller evaluation and measurement according to each item.
Country
South Korea
Verified Certificate
Product name | Cardiac POCT - D-Dimer Immunoassay Test Kit | Certification | CE |
---|---|---|---|
Category | Chemical Reagents & Products | Material | - |
Keyword | diagnostic devices , ivd , poct , fluorescence immunoassay | Unit Size | - |
Brand name | Optical Q | Unit Weigh | - |
origin | South Korea | Stock | 100000 |
Supply type | OBM | HS code | 3822 |
The Optical Q™ D-Dimer diagnostic test is a proprietary point-of-care (POCT) fluorescence immunoassay (FIA) designed for prompt and accurate in-vitro quantitative measurement of D-Dimer.
D-Dimer, containing two D fragments of the fibrin protein joined by a cross-link, is a fibrin degradation product (FDP), which is a small protein fragment present in the blood after a blood clot is degraded by fibrinolysis.
The Optical Q™ D-Dimer reagent test is thus helping diagnose conditions that cause inappropriate blood clots such as deep vein thrombosis (DVT), pulmonary embolism (PE), disseminated intravascular coagulation (DIC), and to monitor treatment of DIC and excessive clotting conditions.
Specifications
Working range | 50-10,000 ng/mL |
Reference range | <500 ng/mL |
CV | <10% |
Sample type | Plasma |
Sample volume | 100 µL |
Loading volume | 100 µL |
Assay time | 15 minutes |
Storage condition | Cartridge: 2-30 °C / Detection buffer: 2-8 °C |
Shelf life | 24 months |
Ordering Information
Cat No. | Description | Packing Size | Storage Condition |
OB141-25 | Optical Q D-Dimer | 25 Test/Box | Cartridge: 2-30℃ Detection Buffer: 2-8℃ |
Price (FOB) | Negotiable | transportation | Air Transportation,Negotiation Other |
---|---|---|---|
MOQ | Negotiable | Leadtime | Negotiable |
Payment Options | T/T | Shipping time | Negotiable |
1 OptiBio Co., Ltd.
-
Country
South Korea
-
President
Jeawon Kim, Minyoung Choi
-
Address
Bonbukwan-401, 76, Yeongudanji-ro, Ochang-eup, Cheongwon-gu, Cheongju-si, Chungcheongbuk-do, Korea
-
Product Category
Other Monitoring & Diagnostic Equipment
-
Year Established
2019
-
Company introduction
OptiBio is a South Korean in-vitro diagnostics (IVD) company focused in researching, developing, and manufacturing cutting edge fluorescence immunoassay (FIA) solutions. In 2020, OptiBio was selected by a research fund sponsored by the Bill & Melinda Gates foundation for its unique and dedicated approach to immunoassay.
OptiBio's competitive advantage stems from its strong foundation of experts, each specialized in fields crucial for product development. Our R&D is divided into 3 different teams of scientists and engineers dedicated to the independent development of diagnostic markers, test kits, and analyzers.
Our fundamental approach to in-house specialization allows OptiBio to constantly improve our product performance, customize our solutions based on client feedback, develop new test parameters, and respond to changing market needs.
OptiBio will continue to create, improve, and innovate world-class diagnostic solutions in the field of fluorescence immunoassay and point-of-care testing (POCT). Through this, we aim to ultimately transform medical diagnosis into a universally available right.
-
Main Markets
-
Brazil
-
Germany
-
Ethiopia
-
Mexico
-
Nigeria
-
- Main Product
- Attached File
-
Verified Certificate
- Other Products from This Supplier
- Related Products
- TRADE SHOWs "Gangwon Expo 2020"
- Other Products viewed with This Product